Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 669 | 7,258 | 7,606 | 10,545 | 10,846 |
| Depreciation Amortization | 7,914 | 6,754 | 6,026 | 5,520 | 5,020 |
| Other Working Capital | -9,261 | -1,861 | -9,224 | 1,955 | 2,795 |
| Other Operating Activity | 3,654 | 3,629 | 6,743 | 2,742 | 2,741 |
| Operating Cash Flow | $2,976 | $15,780 | $11,151 | $20,762 | $21,402 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -36,450 | -70,700 | -54,003 | N/A | N/A |
| Other Investing Activity | 1,681 | 1,505 | 1,378 | 36,564 | 526 |
| Investing Cash Flow | $-34,769 | $-69,195 | $-52,625 | $36,564 | $526 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -90 | -5,955 | -5,939 | N/A | N/A |
| Other Financing Activity | 33,428 | 59,236 | 45,813 | 3,080 | 1,077 |
| Financing Cash Flow | $33,338 | $53,281 | $39,874 | $3,080 | $1,077 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 2,012 |
| Beginning Cash Position | 657 | 791 | 2,391 | 49,997 | 27,204 |
| End Cash Position | 2,202 | 657 | 791 | 7,329 | -5,276 |
| Net Cash Flow | $1,545 | $-134 | $-1,600 | $3,925 | $66 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,976 | 15,780 | 11,151 | 20,762 | 21,402 |
| Free Cash Flow | 2,976 | 15,780 | 11,151 | 20,762 | 21,402 |